-
1
-
-
67649126340
-
Impact of sitagliptin on markers of-cell function: A meta-analysis
-
Riche DM, East HE, Riche KD. Impact of sitagliptin on markers of-cell function: a meta-analysis. Am J Med Sci. 2009;337:321-328.
-
(2009)
Am J Med Sci
, vol.337
, pp. 321-328
-
-
Riche, D.M.1
East, H.E.2
Riche, K.D.3
-
2
-
-
60549111796
-
A biomarker concept for assessment of insulin resistance,-cell function and chronic systemic inflammation in type 2 diabetes mellitus
-
Pfutzner A, Weber MM, Forst T. A biomarker concept for assessment of insulin resistance,-cell function and chronic systemic inflammation in type 2 diabetes mellitus. Clin Lab. 2008;54:485-490.
-
(2008)
Clin Lab
, vol.54
, pp. 485-490
-
-
Pfutzner, A.1
Weber, M.M.2
Forst, T.3
-
3
-
-
0034500397
-
Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic-cell
-
Goodge KA, Hutton JC. Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic-cell. Semin Cell Dev Biol. 2000;11:235-242.
-
(2000)
Semin Cell Dev Biol
, vol.11
, pp. 235-242
-
-
Goodge, K.A.1
Hutton, J.C.2
-
4
-
-
0026726773
-
Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3
-
Smeekens SP, Montag AG, Thomas G, et al. Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci USA. 1992;89:8822-8826.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 8822-8826
-
-
Smeekens, S.P.1
Montag, A.G.2
Thomas, G.3
-
5
-
-
0036679173
-
Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects
-
Zhu X, Zhou A, Dey A, et al. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA. 2002;99:10293-10298.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 10293-10298
-
-
Zhu, X.1
Zhou, A.2
Dey, A.3
-
6
-
-
0346096721
-
Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency
-
Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003;112:1550-1560.
-
(2003)
J Clin Invest
, vol.112
, pp. 1550-1560
-
-
Jackson, R.S.1
Creemers, J.W.2
Farooqi, I.S.3
-
7
-
-
12644253798
-
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2
-
Furuta M, Yano H, Zhou A, et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA. 1997;94:6646-6651.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 6646-6651
-
-
Furuta, M.1
Yano, H.2
Zhou, A.3
-
8
-
-
77953199189
-
Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
-
Heni M, Haupt A, Schafer SA, et al. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet. 2010;11:86.
-
(2010)
BMC Med Genet
, vol.11
, pp. 86
-
-
Heni, M.1
Haupt, A.2
Schafer, S.A.3
-
9
-
-
84855186825
-
Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population
-
Zheng X, Ren W, Zhang S, et al. Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. Mol Biol Rep. 2012; 39:17-23.
-
(2012)
Mol Biol Rep
, vol.39
, pp. 17-23
-
-
Zheng, X.1
Ren, W.2
Zhang, S.3
-
10
-
-
80051937658
-
Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin
-
Wagner R, Dudziak K, Herzberg-Schafer SA, et al. Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin. PLoS One. 2011;6:e23639.
-
(2011)
PLoS One
, vol.6
, pp. e23639
-
-
Wagner, R.1
Dudziak, K.2
Herzberg-Schafer, S.A.3
-
11
-
-
77954145177
-
CommonPCSK1 haplotypes are associated with obesity in the Chinese population
-
Chang YC, Chiu YF, Shih KC, et al.CommonPCSK1 haplotypes are associated with obesity in the Chinese population. Obesity (Silver Spring). 2010;18:1404-1409.
-
(2010)
Obesity (Silver Spring)
, vol.18
, pp. 1404-1409
-
-
Chang, Y.C.1
Chiu, Y.F.2
Shih, K.C.3
-
12
-
-
59449100327
-
Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3)
-
Wen JH, Chen YY, Song SJ, et al. Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia. 2009;52:504-513.
-
(2009)
Diabetologia
, vol.52
, pp. 504-513
-
-
Wen, J.H.1
Chen, Y.Y.2
Song, S.J.3
-
13
-
-
33847617011
-
Mechanisms of action of glucagon-like peptide 1 in the pancreas
-
Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther. 2007;113:546-593.
-
(2007)
Pharmacol Ther
, vol.113
, pp. 546-593
-
-
Doyle, M.E.1
Egan, J.M.2
-
15
-
-
59449101432
-
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): A randomised, 52-week, phase III, double-blind, parallel-treatment trial
-
Garber A, Henry R, Ratner R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. Lancet. 2009;373:473-481.
-
(2009)
Lancet
, vol.373
, pp. 473-481
-
-
Garber, A.1
Henry, R.2
Ratner, R.3
-
16
-
-
39749143348
-
Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic-cell function and argininestimulated insulin secretion during hyperglycaemia in patients with type 2 diabetes mellitus
-
Vilsboll T, Brock B, Perrild H, et al. Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic-cell function and argininestimulated insulin secretion during hyperglycaemia in patients with type 2 diabetes mellitus. Diabet Med. 2008;25:152-156.
-
(2008)
Diabet Med
, vol.25
, pp. 152-156
-
-
Vilsboll, T.1
Brock, B.2
Perrild, H.3
-
17
-
-
2542451393
-
Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): A 12-week, double-blind, randomized, controlled trial
-
Madsbad S, Schmitz O, Ranstam J, Jakobsen G, Matthews DR. Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial. Diabetes Care. 2004;27: 1335-1342.
-
(2004)
Diabetes Care
, vol.27
, pp. 1335-1342
-
-
Madsbad, S.1
Schmitz, O.2
Ranstam, J.3
Jakobsen, G.4
Matthews, D.R.5
-
18
-
-
7444228521
-
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
-
Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care. 2004;27:2628-2635.
-
(2004)
Diabetes Care
, vol.27
, pp. 2628-2635
-
-
Buse, J.B.1
Henry, R.R.2
Han, J.3
Kim, D.D.4
Fineman, M.S.5
Baron, A.D.6
-
19
-
-
33845489598
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
-
Raz I, Hanefeld M,XuL, Caria C, Williams-Herman D, Khatami H. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia. 2006;49:2564-2571.
-
(2006)
Diabetologia
, vol.49
, pp. 2564-2571
-
-
Raz, I.1
Hanefeld, M.2
Xu, L.3
Caria, C.4
Williams-Herman, D.5
Khatami, H.6
-
20
-
-
33845472504
-
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
-
Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care. 2006;29:2632-2637.
-
(2006)
Diabetes Care
, vol.29
, pp. 2632-2637
-
-
Aschner, P.1
Kipnes, M.S.2
Lunceford, J.K.3
Sanchez, M.4
Mickel, C.5
Williams-Herman, D.E.6
-
21
-
-
84862611349
-
Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival
-
Nakashima K, Shimoda M, Hamamoto S, et al. Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival. Mol Cell Endocrinol. 2012;349:281-288.
-
(2012)
Mol Cell Endocrinol
, vol.349
, pp. 281-288
-
-
Nakashima, K.1
Shimoda, M.2
Hamamoto, S.3
-
22
-
-
0035046251
-
Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism
-
Wang X, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. Endocrinology. 2001;142:1820-1827.
-
(2001)
Endocrinology
, vol.142
, pp. 1820-1827
-
-
Wang, X.1
Zhou, J.2
Doyle, M.E.3
Egan, J.M.4
-
23
-
-
0033769693
-
CAMP-GEFII is a direct target of cAMP in regulated exocytosis
-
Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol. 2000;2:805-811.
-
(2000)
Nat Cell Biol
, vol.2
, pp. 805-811
-
-
Ozaki, N.1
Shibasaki, T.2
Kashima, Y.3
-
24
-
-
84857796399
-
Elevated intact proinsulin levels are indicative of-cell dysfunction, insulin resistance, and cardiovascular risk: Impact of the antidiabetic agent pioglitazone
-
Pfutzner A, Forst T. Elevated intact proinsulin levels are indicative of-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone. J Diabetes Sci Technol. 2011;5:784-793.
-
(2011)
J Diabetes Sci Technol
, vol.5
, pp. 784-793
-
-
Pfutzner, A.1
Forst, T.2
-
25
-
-
0031791047
-
Disproportionately elevated proinsulin levels reflect the degree of impaired cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
-
Roder ME, Porte DJ, Schwartz RS, Kahn SE. Disproportionately elevated proinsulin levels reflect the degree of impaired cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:604-608.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 604-608
-
-
Roder, M.E.1
Porte, D.J.2
Schwartz, R.S.3
Kahn, S.E.4
-
26
-
-
0025268864
-
Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus
-
Saad MF, Kahn SE, Nelson RG, et al. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1990;70:1247-1253.
-
(1990)
J Clin Endocrinol Metab
, vol.70
, pp. 1247-1253
-
-
Saad, M.F.1
Kahn, S.E.2
Nelson, R.G.3
-
27
-
-
0027434701
-
Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance
-
Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 1993;76:44-48.
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 44-48
-
-
Reaven, G.M.1
Chen, Y.D.2
Hollenbeck, C.B.3
Sheu, W.H.4
Ostrega, D.5
Polonsky, K.S.6
-
29
-
-
9844258892
-
Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families
-
Humphriss DB, Stewart MW, Berrish TS, et al. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia. 1997;40:1185-1190.
-
(1997)
Diabetologia
, vol.40
, pp. 1185-1190
-
-
Humphriss, D.B.1
Stewart, M.W.2
Berrish, T.S.3
-
30
-
-
15944414254
-
Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: An 11-year follow-up of the Hoorn Study
-
Alssema M, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study. Diabetes Care. 2005;28:860-865.
-
(2005)
Diabetes Care
, vol.28
, pp. 860-865
-
-
Alssema, M.1
Dekker, J.M.2
Nijpels, G.3
Stehouwer, C.D.4
Bouter, L.M.5
Heine, R.J.6
-
31
-
-
79955422864
-
Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance
-
Lee YA, Yoo JH, Kim JH, et al. Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance. Pediatr Diabetes. 2011;12: 235-241.
-
(2011)
Pediatr Diabetes
, vol.12
, pp. 235-241
-
-
Lee, Y.A.1
Yoo, J.H.2
Kim, J.H.3
-
32
-
-
84874537799
-
Association of proinsulin and hepatic steatosis in a random, population-based sample
-
Wengert S, Oeztuerk S, HaenleMM,et al. Association of proinsulin and hepatic steatosis in a random, population-based sample. Eur J Endocrinol. 2013;168:195-202.
-
(2013)
Eur J Endocrinol
, vol.168
, pp. 195-202
-
-
Wengert, S.1
Oeztuerk, S.2
Haenle, M.M.3
-
33
-
-
84876495093
-
Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study
-
Walraven I, van 't Riet E, Stehouwer CD, et al. Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study. Diabetologia. 2013;56:1148-1154.
-
(2013)
Diabetologia
, vol.56
, pp. 1148-1154
-
-
Walraven, I.1
Van 't Riet, E.2
Stehouwer, C.D.3
-
34
-
-
0036175966
-
Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with type 2 diabetes
-
Hanefeld M, Haffner SM, Menschikowski M, et al. Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with type 2 diabetes. Diabetes Res Clin Pract. 2002;55:221-227.
-
(2002)
Diabetes Res Clin Pract
, vol.55
, pp. 221-227
-
-
Hanefeld, M.1
Haffner, S.M.2
Menschikowski, M.3
-
35
-
-
77957659168
-
Limitations of the HOMA-score for assessment of-cell functionality in interventional trialsresults from the PIOglim study
-
Pfutzner A, Derwahl M, Jacob S, et al. Limitations of the HOMA-score for assessment of-cell functionality in interventional trialsresults from the PIOglim study. Diabetes Technol Ther. 2010;12: 599-604.
-
(2010)
Diabetes Technol Ther
, vol.12
, pp. 599-604
-
-
Pfutzner, A.1
Derwahl, M.2
Jacob, S.3
-
36
-
-
8944248809
-
Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with noninsulin-dependent (type 2) diabetes mellitus
-
Nagi DK, Ali VM, Yudkin JS. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with noninsulin-dependent (type 2) diabetes mellitus. Diabet Med. 1996;13: 753-757.
-
(1996)
Diabet Med
, vol.13
, pp. 753-757
-
-
Nagi, D.K.1
Ali, V.M.2
Yudkin, J.S.3
-
37
-
-
0033347050
-
Prolonged exposure of human-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine
-
Hostens K, Ling Z, Van Schravendijk C, Pipeleers D. Prolonged exposure of human-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J Clin Endocrinol Metab. 1999;84:1386-1390.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 1386-1390
-
-
Hostens, K.1
Ling, Z.2
Van Schravendijk, C.3
Pipeleers, D.4
-
38
-
-
0028559815
-
Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome
-
Haffner SM, Mykkanen L, Valdez RA, et al. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab. 1994;79:1806-1810.
-
(1994)
J Clin Endocrinol Metab
, vol.79
, pp. 1806-1810
-
-
Haffner, S.M.1
Mykkanen, L.2
Valdez, R.A.3
-
40
-
-
79955773190
-
Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic-cells
-
Wang J, Chen Y, Yuan Q, Tang W, Zhang X, Osei K. Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic-cells. PLoS One. 2011;6:e19446.
-
(2011)
PLoS One
, vol.6
, pp. e19446
-
-
Wang, J.1
Chen, Y.2
Yuan, Q.3
Tang, W.4
Zhang, X.5
Osei, K.6
-
41
-
-
0027176926
-
Proinsulin levels in newborn siblings of type 1 (insulin-dependent) diabetic children and their mothers
-
Lindgren FA, Hartling SG, Persson BE, et al. Proinsulin levels in newborn siblings of type 1 (insulin-dependent) diabetic children and their mothers. Diabetologia. 1993;36:560-563.
-
(1993)
Diabetologia
, vol.36
, pp. 560-563
-
-
Lindgren, F.A.1
Hartling, S.G.2
Persson, B.E.3
-
42
-
-
84878365678
-
The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: Implications in type 2 diabetes and islet transplantation
-
Park YJ,AoZ, Kieffer TJ, et al. The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation. Diabetologia. 2013;56:508-519.
-
(2013)
Diabetologia
, vol.56
, pp. 508-519
-
-
Park, Y.J.1
Ao, Z.2
Kieffer, T.J.3
-
43
-
-
1442274636
-
Impaired intestinal proglucagon processing in mice lacking prohormone convertase
-
Ugleholdt R, Zhu X, Deacon CF, Orskov C, Steiner DF, Holst JJ. Impaired intestinal proglucagon processing in mice lacking prohormone convertase. Endocrinology. 2004;145:1349-1355
-
(2004)
Endocrinology
, vol.145
, pp. 1349-1355
-
-
Ugleholdt, R.1
Zhu, X.2
Deacon, C.F.3
Orskov, C.4
Steiner, D.F.5
Holst, J.J.6
-
44
-
-
84860324909
-
Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets
-
Alarcon C, Verchere CB, Rhodes CJ. Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets. Endocrinology. 2012;153:2082-2087.
-
(2012)
Endocrinology
, vol.153
, pp. 2082-2087
-
-
Alarcon, C.1
Verchere, C.B.2
Rhodes, C.J.3
-
45
-
-
84861131970
-
Incretin-based therapies and cardiovascular risk
-
Mannucci E, Dicembrini I. Incretin-based therapies and cardiovascular risk. Curr Med Res Opin. 2012;28:715-721.
-
(2012)
Curr Med Res Opin
, vol.28
, pp. 715-721
-
-
Mannucci, E.1
Dicembrini, I.2
-
46
-
-
0028966170
-
Expression and complex formation of soluble N-ethyl-maleimide-sensitive factor attachment protein (SNAP) receptors in clonal rat endocrine cells
-
Oho C, Seino S, Takahashi M. Expression and complex formation of soluble N-ethyl-maleimide-sensitive factor attachment protein (SNAP) receptors in clonal rat endocrine cells. Neurosci Lett. 1995; 186:208-210.
-
(1995)
Neurosci Lett
, vol.186
, pp. 208-210
-
-
Oho, C.1
Seino, S.2
Takahashi, M.3
-
47
-
-
0029983489
-
Protein kinase A-dependent phosphorylation ofGLUT2in pancreatic cells
-
Thorens B, Deriaz N, Bosco D, et al. Protein kinase A-dependent phosphorylation ofGLUT2in pancreatic cells. J Biol Chem. 1996; 271:8075-8081.
-
(1996)
J Biol Chem
, vol.271
, pp. 8075-8081
-
-
Thorens, B.1
Deriaz, N.2
Bosco, D.3
-
48
-
-
0242467078
-
PKAmediated phosphorylation of the human K(ATP) channel: Separate roles of Kir6. 2 and SUR1 subunit phosphorylation
-
Beguin P, Nagashima K, Nishimura M, Gonoi T, Seino S. PKAmediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.EMBOJ. 1999; 18:4722-4732.
-
(1999)
EMBOJ
, vol.18
, pp. 4722-4732
-
-
Beguin, P.1
Nagashima, K.2
Nishimura, M.3
Gonoi, T.4
Seino, S.5
-
49
-
-
0032545328
-
A family of cAMPbinding proteins that directly activate Rap1
-
Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMPbinding proteins that directly activate Rap1. Science. 1998;282: 2275-2279.
-
(1998)
Science
, vol.282
, pp. 2275-2279
-
-
Kawasaki, H.1
Springett, G.M.2
Mochizuki, N.3
-
50
-
-
33751241720
-
Epac proteins: Multi-purpose cAMP targets
-
Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci. 2006;31:680-686.
-
(2006)
Trends Biochem Sci
, vol.31
, pp. 680-686
-
-
Bos, J.L.1
-
51
-
-
0033304977
-
Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic-cells independently of protein kinase A
-
Bode HP, Moormann B, Dabew R, Goke B. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic-cells independently of protein kinase A. Endocrinology. 1999;140:3919-3927.
-
(1999)
Endocrinology
, vol.140
, pp. 3919-3927
-
-
Bode, H.P.1
Moormann, B.2
Dabew, R.3
Goke, B.4
-
52
-
-
0027360242
-
Pancreatic cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets
-
Ishihara H, Asano T, Tsukuda K, et al. Pancreatic cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia. 1993;36:1139-1145.
-
(1993)
Diabetologia
, vol.36
, pp. 1139-1145
-
-
Ishihara, H.1
Asano, T.2
Tsukuda, K.3
-
53
-
-
0030033858
-
Glucoseregulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line
-
Skelly RH, Schuppin GT, Ishihara H, Oka Y, Rhodes CJ. Glucoseregulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line. Diabetes. 1996;45:37-43.
-
(1996)
Diabetes
, vol.45
, pp. 37-43
-
-
Skelly, R.H.1
Schuppin, G.T.2
Ishihara, H.3
Oka, Y.4
Rhodes, C.J.5
-
54
-
-
0028099196
-
Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans
-
Martin SK, Carroll R, Benig M, Steiner DF. Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS Lett. 1994;356:279-282.
-
(1994)
FEBS Lett
, vol.356
, pp. 279-282
-
-
Martin, S.K.1
Carroll, R.2
Benig, M.3
Steiner, D.F.4
-
55
-
-
84868193842
-
Alocal glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
-
Marchetti P, Lupi R, Bugliani M, et al.Alocal glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia. 2012; 55:3262-3272.
-
(2012)
Diabetologia
, vol.55
, pp. 3262-3272
-
-
Marchetti, P.1
Lupi, R.2
Bugliani, M.3
-
56
-
-
80555157690
-
Processing of proglucagon to GLP-1 in pancreatic-cells: Is this a paracrine mechanism enabling GLP-1 to act on-cells?
-
Whalley NM, Pritchard LE, Smith DM, White A. Processing of proglucagon to GLP-1 in pancreatic-cells: is this a paracrine mechanism enabling GLP-1 to act on-cells? J Endocrinol. 2011;211:99-106.
-
(2011)
J Endocrinol
, vol.211
, pp. 99-106
-
-
Whalley, N.M.1
Pritchard, L.E.2
Smith, D.M.3
White, A.4
-
57
-
-
33748603481
-
Improving function and survival of pancreatic islets by endogenous production of glucagonlike peptide 1 (GLP-1)
-
Wideman RD, Yu IL, Webber TD, et al. Improving function and survival of pancreatic islets by endogenous production of glucagonlike peptide 1 (GLP-1). Proc Natl Acad Sci USA. 2006;103:13468-13473.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 13468-13473
-
-
Wideman, R.D.1
Yu, I.L.2
Webber, T.D.3
|